| (Values in U.S. Thousands) | Sep, 2025 | Jun, 2025 | Mar, 2025 | Dec, 2024 | Sep, 2024 |
| Sales | 11,010 | 3,060 | 2,750 | 16,360 | 12,600 |
| Sales Growth | +259.80% | +11.27% | -83.19% | +29.84% | +450.22% |
| Net Income | -7,550 | -24,300 | -24,120 | -14,120 | -11,500 |
| Net Income Growth | +68.93% | -0.75% | -70.82% | -22.78% | +52.62% |
Mersana Therapeutics Inc (MRSN)
Mersana Therapeutics Inc
(MRSN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31